Deborah Taylor Tate, a director at HealthStream, Inc., has filed to sell 3,281 shares of the company's common stock. This transaction is valued at approximately $106,000 and was reported on November 5, 2026. Such executive sales can often influence investor sentiment and market perceptions.

HealthStream, Inc. is a company that operates in the services sector, specifically under the category of computer programming and data processing. The company is incorporated in Tennessee and is listed on the Nasdaq exchange, with a Central Index Key (CIK) of 0001095565. The recent filing is part of Tate's ongoing management of her stock holdings in the company.

The filing indicates that Tate acquired the shares through restricted share units, with the most recent shares acquired on June 6, 2025. The filing states, "Deborah Taylor Tate (HSTM) intends to sell these securities as part of her investment strategy." This sale is part of a broader trend where executives in the tech services industry are actively managing their stock portfolios.

This transaction may affect investors and market analysts who track executive movements and their implications for company performance. The stock sale comes at a time when HealthStream and its competitors are navigating a competitive landscape in the tech services sector.

The filing does not specify what happens next regarding the sale or any future transactions by Tate.